StockDriftsStockDriftsTop 35 Paradigm Biocapital Advisors LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ACLX | ARCELLX INC | 13.55% | 5.77M | $663.0M | +0.87%(+50.00K) | $47.61(+141.71%) | 2026-03-31 | |
| RVMD | REVOLUTION MEDICINES INC | 13.23% | 6.66M | $647.3M | +0.17%(+11.30K) | $37.03(+411.03%) | 2026-03-31 | |
| NUVL | NUVALENT INC | 11.15% | 5.32M | $545.5M | +1.04%(+55.00K) | $59.70(+107.26%) | 2026-03-31 | |
| PCVX | VAXCYTE INC | 5.69% | 4.79M | $278.5M | +17.82%(+725.00K) | $59.36(-1.63%) | 2026-03-31 | |
| EWTX | EDGEWISE THERAPEUTICS INC | 4.74% | 7.37M | $232.0M | +12.59%(+823.83K) | $20.48(+93.18%) | 2026-03-31 | |
| GMAB | GENMAB A/S | 4.37% | 7.97M | $213.8M | +13.18%(+928.00K) | $28.08(+1.54%) | 2026-03-31 | |
| INSM | INSMED INC | 4.19% | 1.25M | $205.1M | new | $134.20(-16.84%) | 2026-03-31 | |
| TARS | TARSUS PHARMACEUTICALS INC | 3.67% | 2.56M | $179.7M | +0.00%(+0) | $28.92(+126.29%) | 2026-03-31 | |
| BLTE | BELITE BIO INC | 3.63% | 1.11M | $177.7M | new | $159.70(-8.18%) | 2026-03-31 | |
| ERAS | ERASCA INC | 3.44% | 10.39M | $168.2M | -26.60%(-3.77M) | $2.20(+738.23%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +18.64% | +67.00% |
| Top 20 Holdings Unweighted | +23.46% | +88.18% |
Sign up free to track Paradigm Biocapital Advisors LP, compare funds side by side, and get alerts the moment positions change.